First Time Loading...

United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 272.69 USD 1.08% Market Closed
Updated: May 16, 2024

P/E
Price to Earnings

11.5
Current
15.2
Median
27.4
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
11.5
=
Market Cap
12.1B
/
Net Income
1.1B
All Countries
Close

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
10.4
2-Years Forward
P/E
10.1
3-Years Forward
P/E
9.6

See Also

Discover More